학술논문
Serum level of soluble triggering receptor expressed on myeloid cells‐1 (sTREM‐1) is a biomarker of synovitis in rheumatoid arthritis.
Document Type
Article
Author
Source
Subject
*SYNOVITIS
*RHEUMATOID arthritis
*SERUM
*CLINICAL drug trials
*
*
*
Language
ISSN
1756-1841
Abstract
Serum level of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) is a biomarker of synovitis in rheumatoid arthritis Baseline serum sTREM-1 level was assessed in 272 patients with available serum samples using enzyme-linked immunosorbent assay (Quantikine, R&D Systems, Lille, France). Characteristics of 272 rheumatoid arthritis patients of the Rotation or Change trial with data available for sTREM-1 included in this ancillary study. [Extracted from the article]